Vanda Pharmaceuticals (VNDA) Declines More Than Market: Some Information for Investors [Yahoo! Finance]
Vanda Pharmaceuticals Inc. (VNDA)
Last vanda pharmaceuticals inc. earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=196233&p=irol-irhome
Company Research
Source: Yahoo! Finance
This change lagged the S&P 500's daily loss of 1.2%. On the other hand, the Dow registered a loss of 0.65%, and the technology-centric Nasdaq decreased by 1.79%. The biopharmaceutical company's shares have seen an increase of 8.14% over the last month, surpassing the Medical sector's loss of 6.57% and the S&P 500's loss of 0.85%. Analysts and investors alike will be keeping a close eye on the performance of Vanda Pharmaceuticals in its upcoming earnings disclosure. The company is expected to report EPS of $0.05, down 16.67% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $48.5 million, down 22.4% from the year-ago period. For the full year, the Zacks Consensus Estimates project earnings of -$0.06 per share and a revenue of $194.5 million, demonstrating changes of -250% and +0.97%, respectively, from the preceding year. Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Vanda Ph
Show less
Read more
Impact Snapshot
Event Time:
VNDA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VNDA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VNDA alerts
High impacting Vanda Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
VNDA
News
- Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals [Yahoo! Finance]Yahoo! Finance
- Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda PharmaceuticalsGlobeNewswire
- Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Vanda (VNDA) to Report Q1 Earnings: What's in the Cards? [Yahoo! Finance]Yahoo! Finance
- Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation [Yahoo! Finance]Yahoo! Finance
VNDA
Earnings
- 2/7/24 - Beat
VNDA
Analyst Actions
- 2/9/24 - TheStreet
VNDA
Sec Filings
- 4/29/24 - Form ARS
- 4/29/24 - Form DEF
- 4/17/24 - Form 8-A12B
- VNDA's page on the SEC website